In the first large trial of its kind, the anti-clotting medication rivaroxaban did not lower the risk of cognitive decline ...

Just 15% of patients have their filters taken out despite clear recommendations they should be removed as soon as feasible.

According to NASS, the Clinical Guidelines were based on a strict analytical process which included a strength of the ...

"This finding came as a surprise, especially in light of the safety guidelines released by the FDA in 2010 and again in 2014, ...

Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...

The improved engagement with HF patients intended to optimize GDMT was very modest, but did lead to increased use of MRAs.

The risks of thromboembolism—blood clots blocking blood flow to organs—following COVID-19 vaccination in patients with atrial ...

USA: A new study from the AUGUSTUS trial has provided new insights into the most effective antithrombotic strategies for ...

Cardiologists from BIDMC, commissioned by the FDA, examined trends in the use and long-term safety of a device for treating ...

"This finding came as a surprise, especially in light of the safety guidelines released by the FDA in 2010 and again in 2014, which strongly advised the prompt removal of IVCFs after their clinical ...

DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.

Peppers, Pharm.D., BCPS Identifying baseline knowledge of epistaxis management in one's practice can assist ... enrolled in the pharmacist-managed anticoagulation clinic. Included patients were ...